Filing Flows › Evolus (EOLS) › Q2 2026 › vs Q1 2026
Evolus (EOLS) Q2 2026 vs Q1 2026 (quarter over quarter)
Evolus's revenue rose $10.9M (+15%) from $73.1M in Q1 2026 to $84.1M in Q2 2026. The biggest changes: Product revenue, net +$10.6M (+15%); Service revenue +$344K (+88%).
Evolus, Q2 2026: revenue $84.1M (+21% year over year), operating margin -5.4%, net loss $8.1M, operating cash flow −$3.6M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Product revenue, net | $83.3M | $72.7M | $10.6M | +15% |
| Service revenue | $734K | $390K | $344K | +88% |
| Revenue | $84.1M | $73.1M | $10.9M | +15% |
| Income tax benefit | $154K | −$256K | $410K | — |
| Net loss | $8.1M | $10.7M | −$2.6M | -25% |
| Costs & expenses | $92.3M | $83.8M | $8.5M | +10% |
| Operating costs | $88.6M | $80.0M | $8.6M | +11% |
| Interest & other, net | $3.7M | $3.6M | $93K | +3% |
| Cost of revenue | $26.9M | $24.2M | $2.7M | +11% |
| Research & development | $1.9M | $2.2M | −$348K | -16% |
| SG&A | $57.1M | $52.0M | $5.1M | +10% |
| Other operating costs | $2.8M | $1.5M | $1.3M | +82% |
| Operating cash sources | $11.5M | $17.4M | −$5.9M | -34% |
| Depreciation & amortization | $2.3M | $2.3M | −$10K | -0.4% |
| Share-based compensation | $5.6M | $5.1M | $506K | +10% |
| Cash used in operations | $3.6M | $10.0M | −$6.4M | -64% |
| Net loss absorbed | $8.1M | $10.7M | −$2.6M | -25% |
| Working capital & other | $3.5M | $6.7M | −$3.2M | -48% |
Questions
How much did Evolus's revenue grow quarter over quarter in Q2 2026?
Evolus's revenue rose $10.9M (+15%) from $73.1M in Q1 2026 to $84.1M in Q2 2026.
What drove Evolus's revenue change in Q2 2026?
Product revenue, net +$10.6M (+15%); Service revenue +$344K (+88%).